newsfilter
← Latest News
Business Wire·

Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference

Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and